Navigation Links
Testosterone Lawsuit News: New Order Outlines Discovery Plan for Federal Testosterone Treatment Litigation, Bernstein Liebhard LLP Reports
Date:9/3/2014

New York, New York (PRWEB) September 03, 2014

Testosterone lawsuits (http://www.testosteronelawsuit2014.com) filed on behalf of men who allegedly suffered serious cardiovascular problems due to their use of AndroGel and other low testosterone therapy medications continue to move forward in U.S. District Court, Northern District of Illinois, Bernstein Liebhard LLP reports. According to a Case Management Order issued on August 25, 2014, the Court has established a discovery plan for the proceeding. Among other things, the Order directs the parties to submit initial disclosures regarding certain potential witnesses and documents within the next 45 days. The parties must also continue negotiations regarding the contents of a Plaintiff’s Fact Sheet in advance of the litigation’s September Status Conference. (In re: Testosterone Replacement Therapy Product Liability Litigation - MDL No. 2545)

“Our Firm has heard from a number of men who were allegedly injured by AndroGel and other prescription treatments for low testosterone. We are pleased to see this litigation moving forward,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is now evaluating testosterone lawsuits on behalf of men who allegedly suffered heart attacks, strokes, deep vein thrombosis, pulmonary embolism and other life-threatening heart problems due to their use of prescription testosterone medications.

Testosterone Treatment Lawsuits

Court documents indicate that just over 170 testosterone treatment lawsuits are now pending in the Northern District of Illinois. All of the claims filed thus far accuse the manufacturers of AndroGel, AndroDerm, Testim and other testosterone replacement therapies of concealing the cardiovascular risks associated with their products, and of failing to warn doctors and patients about their potential to cause serious heart problems.

According to court records, testosterone lawsuit filings began to grow shortly after the U.S. Food & Drug Administration (FDA) announced that it was investigating the cardiovascular risks potentially associated with this class of drugs. The agency is scheduled to convene an outside panel of advisors on September 17th to discuss this matter, and to explore ways in which such risks might be mitigated.

Men who allegedly experienced dangerous cardiovascular events due to low testosterone therapy may be entitled to compensation for their injury-related damages. Find out more about filing a testosterone treatment lawsuit by visiting Bernstein Liebhard LLP’s website, or calling the Firm today at 800-511-5092.

*fda.gov/AdvisoryCommittees/Calendar/ucm404905.htm, FDA, July 17, 2014

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs' Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP

10 East 40th Street

New York, New York 10016

800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:

Felecia L. Stern, Esq.

Bernstein Liebhard LLP

info (at) consumerinjurylawyers (dot) com

http://www.testosteronelawsuit2014.com
https://plus.google.com/115936073311125306742?rel=author

Read the full story at http://www.prweb.com/releases/testosterone-lawsuit/testosterone-heart-attack/prweb12141010.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Methadone treatment suppresses testosterone in opioid addicts
2. Testosterone Therapy Lawsuits: AndroGel Manufacturer Files Petition Against FDA's Decision on Generic Testosterone Treatment Drug
3. Testosterone Treatment Lawsuit News: Federal Court OverseeingTestosterone Litigation Convenes Conference to Discuss Pretrial Management, Bernstein Liebhard LLP Reports
4. Testosterone Lawsuits Involving AndroGel, other Prescription Therapies Move Forward in Illinois Federal Court Litigation, Bernstein Liebhard LLP Reports
5. Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports.
6. Common Chemicals May Lower Testosterone Levels, Study Finds
7. Testosterone Lawsuit Alleges AndroDerm Patch Caused Death of Virginia Man, Bernstein Liebhard LLP Reports
8. Partner Kristine Kraft Appointed to the Plaintiffs’ Steering Committee (PSC) in Federal Testosterone Replacement Therapy MDL, Schlichter, Bogard & Denton, LLP Reports
9. Testosterone in healthy men increases their brains response to threat
10. FDA Seeks Answers As Testosterone Lawsuits Mount Against "Low T" Drug Makers
11. Testosterone Lawsuit News: Bernstein Liebhard LLP Notes Report Indicating That More Men are Seeking Prescription Supplements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... ... in many scientific laboratories. The assembly protocols involve many repetitive steps and often ... for automation, which enables the high-throughput needed, and results in a lower error ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... easier access to the robotic-assisted total-hip and partial-knee replacement surgeries that are ... at Forbes Hospital and Jefferson Hospital recently started performing these surgeries using ...
(Date:3/29/2017)... VA (PRWEB) , ... March 29, 2017 , ... ... its seventh North American office location in Richmond, Virginia, located at the Riverfront Plaza, ... 11, attended by Lieutenant Governor of Virginia Ralph S. Northam and Mayor of Richmond ...
(Date:3/28/2017)... ... ... Tuesday, March 28, 2017, is the annual American Diabetes Association Alert Day, ... find out if they are at risk for developing Type 2 diabetes. In recognition ... by programming the LAX pylons the color red. Downtown’s U.S. Bank Tower Crown Lights ...
(Date:3/28/2017)... ... March 28, 2017 , ... Greenfield Advisors is ... his extensive knowledge of appraisals, property values, ad valorem taxation, and government policy ... industry for more than 40 years. , “Ruel is a great addition to ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... , March 29, 2017   Royal ... leader in health technology, and PathAI, a company ... collaborating with the aim to develop solutions that ... of cancer and other diseases. The partnership aims ... enabling this form of artificial intelligence to be ...
(Date:3/29/2017)... 29, 2017 Neurim Pharmaceuticals ("Neurim") ... obtain exclusive marketing rights for Neurim,s new Rx PedPRM in ... ... treat sleep disorders in children with Autism Spectrum Disorders (ASD) and ... approved for children. The collaboration with Exeltis will help ...
(Date:3/29/2017)... Research and Markets has announced the addition of the ... report to their offering. ... The global patient safety and risk management software market ... Patient safety has become a priority for almost ... significantly in the last decade and is currently on the verge ...
Breaking Medicine Technology: